Clinical Trials List
Protocol NumberMK-3475-A18/ENGOT-cx11
Not yet recruiting
2020-03-01 - 2025-03-31
Phase III
Recruiting3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳祈安 Division of Obstetrics & Gynecology
- 陳宇立 Division of Obstetrics & Gynecology
- 許哲瑜 Division of Radiation Therapy
- 童寶玲 Division of Obstetrics & Gynecology
- 施怡倫 Division of Radiology
- 戴依柔 Division of Obstetrics & Gynecology
- YING-CHENG CHIANG Division of Obstetrics & Gynecology
- 陳苓諭 Division of Radiation Therapy
- CHI-HAU CHEN CHI-HAU CHEN Division of Obstetrics & Gynecology
- 郭冠廷 Division of Others
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 周宏學 Division of Obstetrics & Gynecology
- Cheng-Tao Lin Division of Obstetrics & Gynecology
- 黃意婷 Division of Radiation Therapy
- 黃寬仁 Division of Obstetrics & Gynecology
- 陳威君 Division of Obstetrics & Gynecology
- 江盈瑩 Division of Radiation Therapy
- Chyong-Huey Lai Division of Obstetrics & Gynecology
- Angel Chao Division of Obstetrics & Gynecology
- Chun-Chieh Wang Division of Radiation Therapy
- Huei-Jean Huang Division of Obstetrics & Gynecology
- 黃彥綾 Division of Radiology
- Yun-Hsin Tang Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
980 participants
